Categories AlphaGraphs, Earnings, Technology
AMD Earnings: Advanced Micro Devices Q2 profit rises; revenue up 70%
Chipmaker Advanced Micro Devices, Inc. (NASDAQ: AMD) on Tuesday announced financial results for the second quarter of 2022, reporting a 70% growth in revenues.
Adjusted earnings rose to $1.05 per share in the most recent quarter from $0.63 per share in the second quarter of 2021, and came in above the consensus forecast. Net income was $447 million or $0.27 per share, compared to $710 million or $0.58 per share in the prior-year period.
Check this space to read management/analysts’ comments on AMD’s Q2 2022 results
Second-quarter revenues climbed to $6.55 billion from $3.85 billion in the corresponding period of last year. The top line also exceeded Wall Street’s prediction.
“Each of our segments grew significantly year-over-year, led by higher sales of our data center and embedded products. We see continued growth in the back half of the year highlighted by our next generation 5nm product shipments and supported by our diversified business model,” said AMD’s CEO Lisa Su.
Prior Performance
_________________________________________________________________________________________________________________
Stocks you may like:
International Business Machines Corp. (IBM) Stock
_________________________________________________________________________________________________________________
Most Popular
Key takeaways from Cintas’ (CTAS) third-quarter 2023 report
Cintas Corporation (NASDAQ: CTAS) has been growing its market share by diversifying into new areas and through acquisitions. The prudent business model, with a focus on recurring revenues, has helped
Here are a few points to keep in mind if you are considering Starbucks Corporation (SBUX)
Shares of Starbucks Corporation (NASDAQ: SBUX) stayed in green on Thursday. The stock has gained 10% over the past 12 months. The company delivered healthy results for its most recent
ANGO Earnings: AngioDynamics reports loss for Q3; revenue up 9%
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues increased by 9%. The company also provided guidance for fiscal
